ABBOTT PARK, Illinois
,
August 7, 2023
(press release)
–
Abbott has received U.S. Food and Drug Administration clearance for its advanced Alinity® h-series hematology system, paving the way for laboratories throughout the country to run complete blood counts (CBC) as a part of Abbott’s Alinity family of diagnostic products. Complete blood counts are one of the most ordered tests in the healthcare system and are common in routine checkups because they can help screen for a variety of disorders including infections, anemia, diseases of the immune system, and blood cancers. The Alinity h-series includes Alinity hq, an automated hematology analyzer, and Alinity hs, an integrated slide maker and stainer. A key differentiator for Alinity hq is that it leverages the advanced MAPSSTM technology, which uses light scattering to distinguish cellular features and better identify various blood cells. With the Alinity h-series, Abbott now offers one of the broadest laboratory diagnostic systems, providing a wide array of tests doctors can use to quickly and effectively care for their patients. Laboratories and hospitals across the U.S. will be able to seamlessly integrate the Alinity h-series hematology system into their existing core lab operations, allowing lab staff to easily adopt with minimal effort and training. This is especially important in labs where time, resources and staff are stretched thin. “U.S. healthcare systems have experienced significant resource constraints and rapidly shifting dynamics post-pandemic,” said Louis Morrone, executive vice president for Abbott’s core diagnostics business. “The Alinity h-series system, as with the entire suite of Alinity products, was developed to transform the way laboratories run tests so they can focus on their most important mission: the delivery of patient care.” The Alinity family of systems in the U.S. now includes the Alinity h-series (hematology), Alinity ci (clinical chemistry and immunoassay), Alinity m, (molecular), Alinity s (transfusion) and the point-of-care i-STAT Alinity. The Alinity h-series system offers several advantages for laboratories: About Alinity About Abbott Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 115,000 colleagues serve people in more than 160 countries. Connect with us at www.abbott.com, on LinkedIn at www.linkedin.com/company/abbott-/, on Facebook at www.facebook.com/Abbott and on Twitter @AbbottNews.
Abbott's Alinity family of harmonized solutions is unprecedented in the diagnostics industry, working together to address the challenges of using multiple diagnostic platforms and simplifying diagnostic testing. Alinity systems are designed to be more efficient – running more tests in less space, generating test results faster and minimizing human errors – while continuing to provide quality results. The availability of the Alinity systems and tests varies by geography. More information is available at alinity.com.
* All content is copyrighted by Industry Intelligence, or the original respective author or source. You may not recirculate, redistrubte or publish the analysis and presentation included in the service without Industry Intelligence's prior written consent. Please review our terms of use.
